FGF2 and cancer: Further even though the cancer cell lines used in this study variably expressed FGFR1-4 (Supplementary Fig. 7c), neither BGJ398 nor recombinant FGF2 in tissue culture altered the best described downstream mediators of FGFR signalling, pERK and pAKT (Supplementary Fig. 7d, e).